Last year was called the year of Ozempic, though it was also a year of Ozempic backlash and Ozempic shortages, which could persist for years. Even so, we appear very far from a peak for GLP-1 ...
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, launched an ...
Sen. Bernie Sanders, chair of the Senate Health, Education, Labor and Pensions Committee, has demanded to know why Americans ...
Eli Lilly has made inroads in the red-hot weight-loss market thanks to its diabetes blockbuster, Mounjaro.
The U.S. Senate will investigate the price of Novo Nordisk's popular weight loss and diabetes drugs Ozempic and Wegovy. Sen. Bernie Sanders asked Novo Nordisk's CEO in a letter how the price of ...
Ozempic seems like a wonder drug that's changing people's lives and could have profound effects on the entire economy. It also seems like it has generated at least a million dollars for David Paton.
Novo Nordisk, the maker of popular drugs used for weight loss including Ozempic and Wegovy, says it is investing over $6 billion dollars to help meet the increased demand for the drugs amid ...
Medicare Part D, which provides prescription drug coverage, will now cover the weight-loss medication Wegovy in cases where the patient is at risk of a heart attack or a stroke. Medicare ...
Has Ozempic and its glucagon-like peptide 1 (GLP-1) next of kin found their place alongside Swiss army knives and jacks of all trades? A new report published by the Journal of American Medical ...
Three years ago injecting yourself skinny seemed positively futuristic. Now, everyone from Oprah Winfrey and Elon Musk to your local hairdresser are cashing in on Ozempic’s weight loss benefits.
The Danish firm - controlled by the world's biggest charitable foundation - became Europe's biggest company by stock market ...
Goldman Sachs said Amgen's experimental GLP-1 drug could have peak sales of $5 billion, or 5% of the estimated $100 billion weight loss drug market.